(MedPage Today) -- Another popular guest post on healthy hearts, the worsening Ebola crisis, and a widely panned ASN statement topped this week's news at MedPage Today.
(MedPage Today) -- The FDA approved another once-daily bronchodilator, olodaterol (Striverdi Respimat), for maintenance treatment of chronic obstructive pulmonary disease (COPD).
(MedPage Today) -- Do you think medical residents today are less prepared than they used to be, and what reforms would you want for government funding and oversight of physician education?
(MedPage Today) -- This week's topics include the benefits of running, guidelines for managing stable ischemic heart disease, the health benefits of consuming fruits and vegetables, and screening adolescents for substance abuse.
(MedPage Today) -- Women who are overweight or obese, particularly those becoming so by late adolescence, have an elevated risk for developing rheumatoid arthritis.
(MedPage Today) -- Dementia patients get more implantable cardioverter-defibrillators than expected, and even cognitively normal individuals may not understand their options about cardiac device replacement.
(MedPage Today) -- Welcome to another edition of the MedPage Today Tweet of the Week! Every Friday, the editorial team highlights its favorite 140-character contribution from the healthcare twittersphere.
(MedPage Today) -- The FDA has approved the SGLT2 inhibitor empagliflozin (Jardiance) for type 2 diabetes, the agency announced.
(MedPage Today) -- Studies making an impact in endocrinology this week: when to sample testosterone, drugs and bone risk.
WASHINGTON (MedPage Today) -- Congress approved legislation to improve healthcare access for veterans, sending it to President Obama for his signature.